EIF2AK3 and neoplasm: Of interest, the mouse hosting the one EP tumour that was refractory to pERK modulation owing to apparently reactivated RAS pathway signalling (tumour 12 in Fig. 5b) survived for more than half a year on treatment, longer than any other mouse in the study.